| 英文名稱 | Troxacitabine (Synonyms: BCH 4556; L-OddC; SPD 758) |
|---|---|
| 中文名稱 | 4-氨基-1-((2S,4S)-2-(羥甲基)-1,3-二氧雜戊環(huán)-4-基)嘧啶-2(1H)-酮; 曲沙他濱 |
| CAS號 | 145918-75-8 |
| 分子式 | C8H11N3O4 |
| 分子量 | 213.19 |
| MDL | MFCD00871100 |
| 外觀 | White to off-white powder |
| 儲存條件 | 4°C, protect from light |
| 英文名稱 | Troxacitabine (Synonyms: BCH 4556; L-OddC; SPD 758) |
|---|---|
| 中文名稱 | 4-氨基-1-((2S,4S)-2-(羥甲基)-1,3-二氧雜戊環(huán)-4-基)嘧啶-2(1H)-酮; 曲沙他濱 |
| CAS號 | 145918-75-8 |
| 分子式 | C8H11N3O4 |
| 分子量 | 213.19 |
| MDL | MFCD00871100 |
| 外觀 | White to off-white powder |
| 儲存條件 | 4°C, protect from light |
Troxacitabine, a DNA polymerase inhibitor, shows potential in treating acute myeloid leukemia (AML) and has demonstrated activity against pancreatic cancer cell lines MiaPaCa and Panc-01, with greater efficacy against Panc-01. As a nucleoside analog, it possesses significant anticancer properties.
PMID: 10778991
Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts
PMID: 12451476 DOI: 10.1007/s00280-002-0530-7